Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Tags: cancer, chemotherapy, Docefrez®, taxane, Taxotere®
BASi Method Number SAP.1101
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
